Contribution of recruitable follicles to circulating anti-Müllerian hormone levels following maximal gonadotrophin stimulation in patients with limited ovarian reserve

References

• Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20:370–385.
   PubMed Web of Science ®Google Scholar
• Broer SL, van Disseldorp J, Broeze KA, et al. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update. 2013;19:26–36.
   PubMed Web of Science ®Google Scholar
• Kristensen SG, Mamsen LS, Jeppesen JV, et al. Hallmarks of human small Antral follicle development: implications for regulation of ovarian steroidogenesis and selection of the dominant follicle. Front Endocrinol. 2018;8:376.
   PubMed Web of Science ®Google Scholar
• Lee JR, Kim SH, Kim SM, et al. Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction. Hum Reprod. 2010;25:2597–2604.
   PubMed Web of Science ®Google Scholar
• Styer AK, Gaskins AJ, Brady PC, et al. Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes. Fertil Steril. 2015;104:1153–1161.
   PubMed Web of Science ®Google Scholar
• Weintraub A, Margalioth EJ, Ben CA, et al. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders. Eur J Obstet Gynecol Reprod Biol. 2014;176:163–167.
   PubMed Web of Science ®Google Scholar
• Li Y, Nie M, Liu Y, et al. The dynamic changes of anti-Mullerian hormone and inhibin B during controlled ovarian hyperstimulation in decreased ovarian reserve women and the effect on clinical outcome. Gynecol Endocrinol. 2015;31:450–453.
   PubMed Web of Science ®Google Scholar
• Fanchin R, Schonäuer LM, Righini C, et al. Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation. Hum Reprod. 2003;18:328–332.
   PubMed Web of Science ®Google Scholar
• Melado Vidales L, Fernández-Nistal A, Martínez Fernández V, et al. Anti-Müllerian hormone dynamics during GnRH-antagonist short protocol for IVF/ICSI in women with varying ovarian reserve levels. Minerva Ginecol. 2017;69:128–134.
   PubMed Web of Science ®Google Scholar
• Böttcher B, Tsybulyak I, Grubinger T, et al. Dynamics of anti-Müllerian hormone during controlled ovarian stimulation. Gynecol Endocrinol. 2014;30:121–125.
   PubMed Web of Science ®Google Scholar
• Eldar-Geva T, Margalioth EJ, Gal M, et al. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod. 2005;20:1814–1819.
   PubMed Web of Science ®Google Scholar
• Grynnerup AG, Løssl K, Pilsgaard F, et al. Prediction of the lower serum anti-Müllerian hormone threshold for ovarian stimulation prior to in-vitro fertilization using the Elecsys® AMH assay: a prospective observational study. Reprod Biol Endocrinol. 2019;17:11.
   PubMed Web of Science ®Google Scholar
• Yates AP, Rustamov O, Roberts SA, et al. Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF. Hum Reprod. 2011;26:2353–2362.
   PubMed Web of Science ®Google Scholar
• Tadros T, Tarasconi B, Nassar J, et al. New automated antimüllerian hormone assays are more reliable than the manual assay in patients with reduced antral follicle count. Fertil Steril. 2016;106:1800–1806.
   PubMed Web of Science ®Google Scholar
• Genro VK, Grynberg M, Scheffer JB, et al. Serum anti-Müllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation. Hum Reprod. 2011;26:671–677.
   PubMed Web of Science ®Google Scholar
• Fanchin R, Méndez Lozano DH, Louafi N, et al. Dynamics of serum anti-Müllerian hormone levels during the luteal phase of controlled ovarian hyperstimulation. Hum Reprod. 2005;20:747–751.
   PubMed Web of Science ®Google Scholar
• Griesinger G, Dafopoulos K, Buendgen N, et al. Elimination half-life of anti-Müllerian hormone. J Clin Endocrinol Metab. 2012;97:2160–2163.
   PubMed Web of Science ®Google Scholar
• Weenen C, Laven JSE, Von Bergh ARM, et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10:77–83.
   PubMed Web of Science ®Google Scholar
• Craig J, Orisaka M, Wang H, et al. Gonadotropin and intra-ovarian signals regulating follicle development and atresia: the delicate balance between life and death. Front Biosci. 2007;12:3628–3639.
   PubMed Web of Science ®Google Scholar
• Jeppesen JV, Anderson RA, Kelsey TW, et al. Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod. 2013;19:519–527.
   PubMed Web of Science ®Google Scholar
• Ubaldi FM, Capalbo A, Vaiarelli A, et al. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation. Fertil Steril. 2016;105:1488–1495.
   PubMed Web of Science ®Google Scholar
• Moffat R, Pirtea P, Gayet V, et al. Dual ovarian stimulation is a new viable option for enhancing the oocyte yield when the time for assisted reproductive technology is limited. Reprod Biomed Online. 2014;29:659–661.
   PubMed Web of Science ®Google Scholar
• Cimadomo D, Vaiarelli A, Colamaria S, et al. Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle. Hum Reprod. 2018;33:1442–1448.
   PubMed Web of Science ®Google Scholar